De Rasmo, D.; Ferretta, A.; Russo, S.; Ruggieri, M.; Lasorella, P.; Paolicelli, D.; Trojano, M.; Signorile, A.
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels. Biomedicines 2020, 8, 85.
https://doi.org/10.3390/biomedicines8040085
AMA Style
De Rasmo D, Ferretta A, Russo S, Ruggieri M, Lasorella P, Paolicelli D, Trojano M, Signorile A.
PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels. Biomedicines. 2020; 8(4):85.
https://doi.org/10.3390/biomedicines8040085
Chicago/Turabian Style
De Rasmo, Domenico, Anna Ferretta, Silvia Russo, Maddalena Ruggieri, Piergiorgio Lasorella, Damiano Paolicelli, Maria Trojano, and Anna Signorile.
2020. "PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels" Biomedicines 8, no. 4: 85.
https://doi.org/10.3390/biomedicines8040085
APA Style
De Rasmo, D., Ferretta, A., Russo, S., Ruggieri, M., Lasorella, P., Paolicelli, D., Trojano, M., & Signorile, A.
(2020). PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels. Biomedicines, 8(4), 85.
https://doi.org/10.3390/biomedicines8040085